Prostate cancer incidence rates have started to decrease in central Italy

Journal of Medical Screening

Volumn 17, Issue 1, 2010, Pages 50-51

  Crocetti, Emanuele ^a   Ciatto, Stefano ^a   Buzzoni, Carlotta ^b   Zappa, Marco ^a  

^a Clinical and Descriptive Epidemiology Unit ISPO   (Italy)

^b Verona Local Health Authority   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; HUMAN; ITALY; MALE; METABOLISM; PROSTATE TUMOR;

HUMANS; ITALY; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 77950643727     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1258/jms.2009.009123     Document Type: Article

References (4)

1. Schröder FH, Hugosson J, Roobol MJ, et al. ERSPC investigators: screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009;360: 1320-1328
2. See http://seer.cancer.gov/faststats (last checked 16 December 2009)
3. Barchielli A, Crocetti E, Zappa M. Has the PSA wave already crashed upon us? Changes in the epidemiology of prostate cancer from 1985 to 1994 in central Italy. Ann Oncol 1999;10:361-2
4. Ciatto S, Houssami N, Martinelli F, Giusti F, Zappa M. PSA use and incidence of prostate biopsy in the Tuscany region: is opportunistic screening discounting biopsy in subjects with PSA elevation? Tumori 2008;94:518-22.